BRCC Portfolio of Companies

Pharmaceutical Services

  • Medicinal chemistry

 Pharmaceutical Services

  • Preclinical development services including bio-analytics, animal studies

 Drug Discovery

  • Novel therapy for noise-induced hearing loss

Drug Discovery

  • New use for marketed drug in women’s health

 

 Drug Discovery

  • Novel therapies for heart failure and muscular dystrophy

 Pharmaceutical Services

  • In vitro toxicology services

 Pharmaceutical Services

  • Custom protein synthesis

 

Drug Discovery

  • Novel therapies that target DNA to treat cancer and other complex genetic diseases

Pharmaceutical Services

  • Drug metabolism, disposition, and pharmacokinetics for drug discovery

Drug Discovery

  • Novel therapies for cervical cancer

logo

Pharmaceutical Services

  • Novel drug encapsulation technique to prepare blinded drug supplies for the pharmaceutical industry

Drug Discovery

  • Novel antifungal agents

Drug Discovery

  • Novel chemistry platform for kinase inhibitors for cancer and inflammatory diseases

Drug Discovery

  • Novel chemistry techniques to improve pharmacologic properties of existing drugs

 Drug Discovery

  • Novel therapy for inflammatory bowel disease

Drug Discovery

  • Novel therapies for renal failure and possibly other gastrointestinal disorders

Oval: Micromyx

 Pharmaceutical Services

  • Screening Services for antibiotic drug discovery

 Pharmaceutical Services

  • High throughput screening services for the pharmaceutical industry

Drug Discovery

  • Novel, nanotechnology based drug delivery technology licensed from University of Kentucky
  • Technology being applied to improve efficacy of existing anti-cancer agent

Medical Device

  • Novel acellular medical device for the treatment of acute renal failure
  • Based on technology licensed from the University of Michigan and RenaMed, Inc.

Pharmaceutical Services and Drug Discovery

  • AFID Therapeutics develops proprietary chemical compounds that are used by pharmaceutical chemistry and drug discovery and development companies to create new medicines.
  • Based on technology licensed from Michigan State University

Pharmaceutical Services

  • Preclinical formulation development, analytical services and early phase GMP clinical supplies